IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy
1 clinical trials · Condition
◉ Watch IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Toripalimab (JS001) Combined With Pemetrexed and Anlotinib for Patients With T790M Positive Non-Small Cell Lung Cancer After Osimertinib Resistance (NCT04316351) | Guangzhou Institute of Respiratory Disease | 2020-04-01 |
Track IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy automatically
Every clearance here is in the API, with alerts when new ones post.